Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2021
- Last Action
- 6/21/2021
Actions
- 2021-06-21Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4657)
- 2021-06-21Introduced in Senate
CRS Summary
As of 2021-06-21 (00)
Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2021
This bill establishes the Task Force on Innovative Diabetes Technologies and Services to address the accessibility of innovative diabetes technologies and services to Medicare beneficiaries. The bill defines innovative diabetes technologies and services as medical technologies and services for diabetes treatment that are not covered under Medicare.
Among other activities, the task force must (1) recommend ways to improve access to innovative diabetes technologies and services through new or alternative payment models and existing policies, and (2) propose changes to foster collaboration between the Food and Drug Administration and the Centers for Medicare & Medicaid Services to streamline approval and coverage.
Cosponsors (1)
- Jeanne Shaheen (D-NH)
Subjects
- Administrative law and regulatory procedures
- Advanced technology and technological innovations
- Advisory bodies
- Congressional oversight
- Department of Health and Human Services
- Digestive and metabolic diseases
- Drug safety, medical device, and laboratory regulation
- Health care coverage and access
- Health technology, devices, supplies
- Medical research
- Medicare
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.